Vir Biotechnology, Inc. Income Tax Expense (Benefit) in USD from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Vir Biotechnology, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2017 to Q3 2025.
  • Vir Biotechnology, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $168K, a 5.09% decline year-over-year.
  • Vir Biotechnology, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $268K.
  • Vir Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2024 was -$1.15M, a 91.2% increase from 2023.
  • Vir Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2023 was -$13.1M.
  • Vir Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2022 was $238M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

Vir Biotechnology, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $268K $168K -$9K -5.09% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $277K $170K +$1.68M Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 -$1.41M $16K -$260K -94.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$1.15M -$86K +$4.7M +98.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$5.84M $177K +$3.39M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 -$9.23M -$1.51M +$1.34M +46.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 -$10.6M $276K +$2.51M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 -$13.1M -$4.78M Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$3.21M -$45.6M -108% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$2.85M +$154M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$2.23M -$406M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q3 2022 $309M $42.4M +$42.1M +12601% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $267M -$157M* -$157M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $424M $403M* +$403M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $21.2M $20.6M +$20.7M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $553K $334K +$312K +1418% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $241K $53K +$7K +15.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $234K $196K +$180K +1125% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $54K -$30K Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $22K +$35K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $46K +$27K +142% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $16K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 -$13K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $19K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11

Vir Biotechnology, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1.15M +$11.9M +91.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$13.1M -$252M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $238M* +$217M Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $21.2M +$21.2M +39193% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $54K -$100K -64.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $154K +$634K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$480K +$10.4M +95.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$10.9M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.